However, it is noteworthy that PAX2 was found to be reactivated in renal cell carcinoma and that around 90% of renal cell carcinoma patients have high PAX2 and PAX8 expression levels [5,15]. The gene discussed is PAX2; the disease is hereditary clear cell renal cell carcinoma.